Oral nicotine marketing claims in direct-mail advertising
- PMID: 33958422
- PMCID: PMC9411885
- DOI: 10.1136/tobaccocontrol-2020-056446
Oral nicotine marketing claims in direct-mail advertising
Abstract
Background: Little is known regarding how oral nicotine products (eg, nicotine pouches, lozenges) are marketed to consumers, including whether potential implicit reduced harm claims are used. In the current study, we explored the marketing claims present in a sample of direct-mail oral nicotine advertisements sent to US consumers (March 2018-August 2020).
Methods: Direct-mail ads (n=50) were acquired from Mintel and dual-coded for the following claims: alternative to other tobacco products, ability to use anywhere, spit-free, smoke-free and product does not contain tobacco leaf. We merged the coded data with Mintel's volume estimate (number of mail pieces sent to consumers) and calculated the proportion of oral nicotine advertisements containing claims by category.
Results: Of the 38 million pieces of oral nicotine direct-mail sent to US consumers, most featured claims that the product could be used anywhere (84%, 31.8 million pieces); was an alternative to other tobacco products (69%, 26.1 million pieces); and did not contain tobacco leaf (eg, 'tobacco leaf-free', 'simple' approach of extracting nicotine from tobacco; 55%, 20.7 million pieces). A slightly smaller proportion contained claims that oral nicotine was 'spit-free' (52%, 19.8 million pieces) or 'smoke-free' (31%, 11.7 million pieces).
Conclusion: Our results provide an early indication of marketing claims used to promote oral nicotine. The strategies documented, particularly the use of language to highlight oral nicotine is tobacco-free, may covey these products as lower-risk to consumers despite the lack of evidence or proper federal authorisation that oral nicotine products are a modified-risk tobacco product. Future research is needed to examine consumer perceptions of such claims.
Keywords: non-cigarette tobacco products; public policy; surveillance and monitoring.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.MMWR Surveill Summ. 2022 Mar 11;71(5):1-29. doi: 10.15585/mmwr.ss7105a1. MMWR Surveill Summ. 2022. PMID: 35271557 Free PMC article.
-
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.Health Technol Assess. 2024 Oct;28(73):1-230. doi: 10.3310/YAPL9347. Health Technol Assess. 2024. PMID: 39487661 Free PMC article.
-
Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2024 Oct;28(75):1-75. doi: 10.3310/TGAC4201. Health Technol Assess. 2024. PMID: 39487741 Free PMC article.
-
Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review.
-
Toward an ontology of identity-related constructs in addiction, with examples from nicotine and tobacco research.Addiction. 2023 Mar;118(3):548-557. doi: 10.1111/add.16079. Epub 2022 Nov 24. Addiction. 2023. PMID: 36370069 Review.
Cited by
-
Use of Traditional Smokeless, Snus, and Dissolvable Tobacco Among U.S. Youth.Am J Prev Med. 2023 Feb;64(2):204-212. doi: 10.1016/j.amepre.2022.09.011. Epub 2022 Nov 3. Am J Prev Med. 2023. PMID: 36335080 Free PMC article.
-
Nicotine pouch awareness, use and perceptions among young adults from six metropolitan statistical areas in the United States.Tob Prev Cessat. 2023 Jun 7;9:19. doi: 10.18332/tpc/163243. eCollection 2023. Tob Prev Cessat. 2023. PMID: 37293565 Free PMC article.
-
A Content Analysis of Promotional Features in US Direct-Mail From Advertisements Across Tobacco Products From 2018 to 2020.Nicotine Tob Res. 2022 Oct 17;24(10):1627-1634. doi: 10.1093/ntr/ntac095. Nicotine Tob Res. 2022. PMID: 35417549 Free PMC article.
-
Characterising advertising strategies and expenditures for conventional and newer smokeless tobacco products.Tob Control. 2023 Nov;32(6):795-798. doi: 10.1136/tobaccocontrol-2022-057282. Epub 2022 Jul 8. Tob Control. 2023. PMID: 35803674 Free PMC article.
-
Tobacco Free Nicotine Vaping Products: A Study of Health Halo Effects Among Middle School Youth.J Health Commun. 2023 Jun 3;28(6):391-400. doi: 10.1080/10810730.2023.2217431. J Health Commun. 2023. PMID: 37340942 Free PMC article.
References
-
- Food and Drug Administration . Smokeless tobacco products, including dip, snuff, Snus, and chewing tobacco, 2020. Available: https://www.fda.gov/tobacco-products/products-ingredients-components/smo...
-
- Food and Drug Administration . Dissolvable tobacco products, 2018. Available: https://www.fda.gov/tobacco-products/products-ingredients-components/dis...
-
- Kary T, Gretler C. Big tobacco hopes oral nicotine pouches fill the Vaping void. Bloomberg Businessweek, 2020. Available: https://www.bloomberg.com/news/articles/2020-07-17/big-tobacco-hopes-ora...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical